Skip to main content
. 2023 Jul 12;23:464. doi: 10.1186/s12879-023-08448-w

Table 2.

Geometric means of antibody titer (BAU/mL) stratified by age group and measurement week

September 2021 December 2021 February 2022 September vs. December December vs. February
Geometric mean of antibody titer (BAU/mL) Hodges-Lehmann estimate [95% CI]&
Pfizer or Moderna
18–25 780.5 295.6 1397.8 834.0 [346.2,1149.3]***

-1064.0

[-820.2, -1288.5]***

26–35 797.1 254.0 1174.1

681.0

[518.9, 852.9]***

-981.2

[-831.9, -1130.9]***

36–45 582.4 243.2 1178.7

456.6

[368.4, 548.8]***

-1001.5

[-827.7, -1215.1]***

46–55 572.9 212.0 1766.7

442.1

[362.6, 519.8]***

-1793.8

[-1564.3, -2039.0]***

56–65 405.6 164.7 1825.1

219.2

[165.6, 278.6]***

-1848.8

[-1547.5, -2232.3]***

66–75 219.7 108.3 1667.1

98.2

[80.9, 116.5]***

-1633.3

[-1490.6, -1761.9]***

Total 444.2 181.6 1552.9

239.8

[206.5, 277,3]***

-1433.3

[-1355.1, -1510.1]***

Janssen^
36–45 147.5 59.4 1682.3

55.9

[2.8, 272.8]*

-1800.2

[-947.0, -2295.4]***

46–55 92.7 71.9 1107.3

7.4

[-14.2, 28.8]ns

-884.1

[-743.7, -1316.1]***

Total 103.3 68.0 1213.44

14.4

[-1.9, 36.5]ns

-1026.6

[-802.3, -1454,6]***

AstraZeneca #
56–65 90.3 48.5 1155.0

35.6

[21.8, 51.8]***

-1165.9

[-1009.2, -1272.2]***

Previous infection
18–25 1019.7 689.7 1659.6

310.7

[-101.0, 893.1]ns

-889.6

[-411.2, -1448.4]***

26–35 890.6 549.5 1239.4

274.6

[-64.2, 779.9]ns

-595.7

[-238.6, -1005.6]**

36–45 910.1 650.9 1781.0

363.5

[-20.7, 864.2]ns

-984.3

[-519.2, -1490.2]***

46–55 1016.0 679.2 2162.1

417.7

[106.7, 771.2]**

-1432.3

[-1025.8, -1982.2]***

56–65 1027.7 769.8 2625.2

142.8

[-128.4, 443.6]ns

-1784.3

[-1333.4, -2334.0]***

66–75 1099.7 861.8 2985.2

150.4

[-185.4, 503.1]ns

-1712.0

[-1090.0, -2595.9]***

Total 994.2 708.2 2022.7 263.2 [126.8, 416,5]***

-1219.4

[-1015.0, -1432.4]***

^birth cohorts 1967, 1968, and 1976

# birth cohorts 1956–1960

& Tested with Mann-Withney U test

* = p < 0.05, ** = p < 0.01, *** = p < 0.001 ns = not significant